Adore Organic Innovations Anti-aging Claims

October 2018: The appeal was voluntarily dismissed because the objector did not pay the filing and docketing fees.

August 2018: A federal judge granted final approval of the settlement agreement. Later in the month, an objector filed a Notice of Appeal regarding the approval of the settlement.

April 2018: A federal judge preliminarily approved a settlement agreement. According to the settlement terms, class members with proof of purchase may receive either a $25 cash refund or an electronic gift card for 50% of the purchase price for each product purchased (with a maximum award of $200) while class members without proof of purchase may receive one $50 electronic gift card regardless of how many products were purchased. In addition, the company agreed to remove the words “proven” and “breakthrough” and the phrase “most advanced anti-aging science available today” from marketing materials. The company also agreed to not state that the formula contains “live” plant cells. A final fairness hearing is scheduled for August 10, 2018.

April 2017: This action was transferred to a Florida Court. (Case No. 17-cv-21468, S. D. FL.)

September 2016: A class-action lawsuit was filed against Adore Organic Innovations for, among other things, allegedly deceptively marketing the Adore Organic Innovation product line – including the Adore CELLMAX products – as containing an “exclusive Plant Stem Cell Formula” that is “proven to restore youthful appearance by protecting your skin’s own stem cells and encouraging them to regenerate healthy texture” when, according to the plaintiffs, the cosmetics do not provide the advertised anti-aging benefits and the “exclusive” plant stem cells are also found in other cosmetics. (Mollicone et al v. Universal Handicraft, Inc. d/b/a “Deep Sea Cosmetics” d/b/a “Adore Organic Innovations” and Shay Sabag Segev, Case No. 16-cv-7322, C. D. CA.)

For more information about other class-action lawsuits regarding cosmetics and TINA.org’s coverage of the product, click here.